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ABSTRACT
For years, natural polymers have played a significant role in pharmaceutical field due to their 
biocompatibility and biodegradability. In Indonesia, most research in natural polymers focus 
on application of the polymers as inert pharmaceutical excipients or as drug matrix in micro- and 
nano- particle. Meanwhile, research about polymers in the world (mostly synthetic polymers) have 
been progressed to advanced drug delivery system. In this system, the polymer can act as either 
pharmacologically active molecules, or sophisticated carrier in targeted prodrug delivery system. 
The latter is called polymer-drug conjugates, a system where the drugs are covalently attached to a 
polymeric carrier, rather than simply entrapped in polymer matrix. Natural polymers have been one of 
the materials to use for the carrier due to their biocompatibility and biodegradability. This review article 
emphasizes the opportunity, challenges and strategies to use natural polymers as carrier in polymer-
drug conjugates. Moreover, we also discuss some aspects in regards of the synthesis and analysis, 
to give some perspectives and encouragement for the Indonesian researcher who are interested in 
exploring this research field.
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INTRODUCTION
Natural polymers have been extensively used in research 
and development of pharmaceutical products. Their 
applications are mostly on the use of the polymers as 
excipient in pharmaceutical dosage form. In the last 
8 years, research in natural polymer in Indonesia are 
mainly about modifying the polymer to increase the 
performance as matrix in controlled release tablets and 
capsules (Ariani, Surini, & Hayun, 2016; Surini, Nizma, 
& Azizahwati, 2017; Surini, Wati, & Syahdi, 2018) 
gastroretentive drug delivery system (Budianto, Al-
Shidqi, & Cahyana, 2017; Dessy, Siahaan, & Bangun, 
2018), mucoadhesive system (Adliani & Bangun, 
2016; Arianto, Bangun, Harahap, & Ilyas, 2015; Putri, 
Sulistomo, & Surini, 2017), microsphere (Hariyadi et al., 
2014) and microcapsule (Halim, Arianti, & Umar, 2011). 
In those cases, the polymers are supposed to be inert and 
do not chemically interact with the loaded drugs.
Some research in Indonesia also encompassed the use 
of natural polymer as nanoparticle. Martien, Sa’adah, 
& Saifullah (2016) synthesized insulin-loaded chitosan-
pectin nanoparticles via ionic gelation method for oral 
delivery of insulin. Pertiwi, Martien, Sismindari, & 
Ismail (2018) also used chitosan-pectin nanoparticle 
to encapsulate Ribosome Inactivating Protein isolated 
from Mirabilis jalapa L., with particle size ~350 nm. 
Chitosan nanoparticles were also used to encapsulate 
Phaleria macrocarpa leaf extract for suppression of 
mitosis and hyperplasia in small intestine crypt epithelial 
cells (Kusmardi, Ramadhan Tamzir, Widiasari, & 
Estuningtyas, 2018).
Meanwhile, research about polymer worldwide has 
progressed to more advanced drug delivery system 
called polymer therapeutic. Unlikely application of 
polymers only as inert excipients in conventional dosage 
forms, polymer therapeutic require covalent attachment 
between drug and polymer to form new system which 
is considered as new drug. Polymer therapeutic diverse 
to some different systems, including polymeric drug, 
polymer-drug conjugates, polymer-protein conjugate, 
self-assembly polymeric micelles and many more 
(Duncan & Vicent, 2013). Some products of polymer 
therapeutic have reached the market and some are still 
in clinical trials (Atkinson, Andreu, & Vicent, 2018; 
Duncan, 2017). Surprisingly, two compounds of this 
therapeutic group, the white blood cell booster Neulasta® 
and the immunomodulatory drug Copaxone®, became 
Top 10 selling drugs in US (Atkinson et al., 2018; 
Duncan, 2014). 
In Indonesia, research in polymer therapeutic is slightly 
explored. Dendrimers become the most popular 
“polymer” being used as carrier, either for cytotoxic 
drugs (Sagita, Djajadisastra, & Mutalib, 2016) or 
theranostic agents such as 198Au (Halid, Sutriyo, Mutalib, 
Pujiyanto, & Gunawan, 2017) and radiogadolinium 
(III) (Rahmania, Mutalib, Ramli, & Levita, 2015). 
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Nevertheless, research in this area using natural polymer 
has not been found in any international publications 
(searching was filtered by affiliation “Indonesia”).
Therefore, we would like to give some concepts about 
polymer therapeutics using natural polymer as carrier. 
We are interested in using natural polymer due to 
Indonesia’s biodiversity of natural polymer resources 
that can be explored, such as dextrin, chitosan and pectin. 
Besides, their biodegradability and biocompatibility 
provide certain benefits. In this review, we focus only 
on polymer-drug conjugates since they are relatively 
simpler than other systems in polymer therapeutic 
cluster. This review will cover the definition of polymer-
drug conjugates, design of the system and some aspects 
on synthesis and analysis.
Overview of Polymer-Drug Conjugates
Ringsdorf’s Model
Polymer-drug conjugates (PDC) refer to systems which 
consist of polymer as carrier and covalently-attached 
small molecule drugs (Vicent & Duncan, 2006). This 
covalent link is able to provide clinical benefits such 
as alteration in the pharmacokinetics (Danson et al., 
2004; Forrest et al., 2008; Šírová et al., 2017; Vasey et 
al., 1999) and even improve biodistribution of several 
cancer drugs (Ernsting, Tang, MacCallum, & Li, 2012; 
H. Tang et al., 2018). Because of some alterations in 
biological behavior, this system is considered as New 
Chemical Entity (NCE) and should undergo full phase of 
clinical trial (Atkinson et al., 2018). 
Ringsdorf’s model is the generic concept of polymer-drug 
conjugates design with lysosomotropic system, which 
was established in 1975 by Helmut Ringsdorf (Ringsdorf, 
1975). N-(2-hydroxypropyl) methacrylamide (HPMA)-
doxorubicin conjugate was the first to enter Phase 1/II 
clinical trials in 1994 (Duncan & Vicent, 2013). This 
then became the prototype for HPMA-based polymer 
conjugates.
Figure 1. Ringdorf's Model for Polymer-drug 
Conjugates System
In Ringsdorf’s model (Figure 1), the system consists 
of polymer carrier, linker, and conjugated molecules. 
The conjugated molecules can be drugs, targeting 
moieties, or labelling molecules such as fluorophore 
and radioisotope. The covalent conjugation brings 
superiorities such as higher drug loading, controlled drug 
release and minimization of undesirable drug leaking, 
compared to physically encapsulated polymer systems 
(Pang et al., 2016). 
Advantages of Polymer-Drug Conjugates: Role of 
Polymeric Carrier
Conjugating poorly soluble drugs to hydrophilic 
polymer can improve the solubility of the drugs. For 
example, paclitaxel-poly-L-glutamic acid conjugates 
could be dissolved in normal saline, while the free 
paclitaxel required mixture of 50:50 Cremophor-ethanol 
and saline (1:4), for the equivalent amount of paclitaxel 
(Li et al., 1998). Solubility of saquinavir can also be 
enhanced by conjugation with polyethyleneglycol (PEG) 
(Gunaseelan et al., 2004). Another example is solubility 
improvement of a xantin oxidase inhibitor, 4-amino-
6-hydroxypyrazolo[3,4-d]pyrimidine (AHPP), when 
conjugated with styrene maleic acid copolymer (SMA) 
(Fang et al., 2009).
The other advantage of PDC is prolonged plasma 
half-life due to their nano-sized compared to the free 
parent drugs. Depend on the length and shape of the 
polymeric carrier, the hydrodynamic size can range 
from 5 to 200 nm. This size is above the limit of renal 
filtration, which is varied by size but is around 3.5 nm 
(Nishiyama, 2007) and therefore reduce the excretion of 
the conjugates. Moreover, we can decorate the system 
with polyethylene glycol (PEGylation) that act as a 
“shield” and reduce the interaction with phagocytic 
cells. However, the superiority of PEG for drug delivery 
system is being questioned, since numerous studies 
found that PEGylation causes enhanced serum protein 
binding and anti-PEG antibody production (see review 
from Verhoef & Anchordoquy, 2013). A new study 
demonstrated increase anti-PEG antibody production in 
healthy wildtype mice after subsequent administration 
of PEGylated polymeric nanoparticles and liposomes 
(Grenier, de Oliveira Viana, Lima, & Bertrand, 2018)
However, the linear PEG alone was less immunogenic. 
The authors suggested alternative PEGylation strategies 
for future study, for example polymer chains with comb 
architectures, to change the pattern of PEG layer on 
polymers.
Polymer-drug conjugates, as part of nanomedicine, 
has been extensively explored for improving cancer 
therapy by their well-known enhanced permeability and 
retention (EPR) characteristic. The phenomenon is due 
to increase permeability of tumor vasculature that makes 
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macromolecules larger than 40 kDa can extravasate 
and accumulate in tumor tissues, as well as improper 
lymphatic function that reduce the disposal of such 
materials to lymphatic system (Fabienne Danhier, Feron, 
& Préat, 2010; Fang, Nakamura, & Maeda, 2011). This 
is then popularly called passive targeting.
The EPR concept is now a controversy because of the 
heterogeneity of tumor cells (F. Danhier, 2016; Maeda, 
2015). However, conjugation of anticancer drugs to 
nanoparticles or polymer has proved reduced toxicity 
to normal tissues (Ernsting et al., 2012; Lammers et 
al., 2009; H. Tang et al., 2018). Therefore, research 
in polymer-drug conjugates still need to be explored, 
especially with natural polymers, as they are considered 
as biocompatible. Moreover, current application of 
polymeric nanoparticles is not only for cancer therapy 
but also other diseases such as antiinfectives, tissue 
regeneration and repair, wound healing, osteoarthritis, 
rheumatoid arthritis, ischemia, and many more (Duncan 
& Vicent, 2013). 
Drug Release from Conjugate
So if the drugs are covalently attached to the carrier, how 
can the drugs give the same pharmacological effect? 
This is where the “linker” or “spacer” plays a role. As 
we can see in  Ringsdorf’s model, the drug is linked to 
the polymer via a spacer. The linker/spacer should be 
made selectively degradable, which means it will not be 
cleaved in the systemic circulation, but it will undergo 
cleavage when it reaches the site of action to release the 
drugs. This condition may be induced by differences in 
the environment condition between blood circulation 
and site of action such as pH and the presence of specific 
enzyme. Kurtoglu, Mishra, Kannan, & Kannan (2010) 
observed different drug release characteristics from 
dendrimer with different linkers, and found that amide 
linkers were very stable at all pH, while ester and peptide 
linkers showed pH dependent and enzyme-activated 
rates, respectively.
Drug release by pH-dependent hydrolysis provides 
benefit for delivery of anticancer drugs, because tumor 
microenvironment has more acid pH (6.0-7.0) than 
normal plasma (7.4) (Fabienne Danhier et al., 2010). 
Furthermore, the inside of lysosomes, cell organelles 
that digest engulfed foreign particle, have pH 4.0-5.0 
(DiCiccio & Steinberg, 2011), which facilitate rapid 
release of drugs inside the cells. Cisplatin was conjugated 
to modified PEG polymer via ester bond and showed 
different drug release profile in vitro at pH 5.0, 6.0 and 
7.4 (Aryal, Hu, & Zhang, 2010). Hydrazone linkage was 
used to attached paclitaxel to HPMA copolymer (Etrych, 
Milada, Starovoytova, Blanka, & Ulbrich, 2010). The 
conjugates were relatively stable at the pH of blood (7.4) 
and release active drug in pH 5. Du, Du, Mao, & Wang 
(2011) also used hydrazine bond to link doxorubicin to 
polymer.
Enzyme-activated linker involves cleavable peptide 
sequences that are sensitive to specific enzymes such as 
cathepsins, matrix metalloproteases (MMPs), plasmin, 
prostate-specific antigen (PSA) and urokinase (Wong 
& Choi, 2015). Conjugation of paclitaxel and PEG via 
valine–citrulline dipeptide linker showed higher in vitro 
drug release in the existence of Cathepsin B than without 
the enzyme (Liang et al., 2012). GLFG, Gly-Leu-Phe-
Gly, is a tetrapeptide that is also widely used as enzyme-
activated linker (Luo, Yang, Kope Ckov, & Rich Kope, 
2011; Vicent et al., 2005; R. Zhang, Yang, Sima, Zhou, 
& Kopecek, 2014). Another enzyme-sensitive linker is 
N-acetyl-Gly-D-ala-L-Phe-L-Lys that can be degraded 
by both proteases plasmin and cathepsin B (Barthel et 
al., 2012).
Glutathione (GSH) levels in human tissue vary greatly, 
but they tend to be elevated in breast, ovarian, head 
and neck and lung tumors, compared to normal tissue 
(Gamcsik, Kasibhatla, Teeter, & Colvin, 2012). Due to 
this finding, disulfide bond can be a linker for targeted 
drug release which will undergo cleavage through a 
reduction reaction (Wong & Choi, 2015). This has been 
used in synthesis of various polymer drug conjugate 
such as PEG-co-tert butyl acrylate-paclitaxel (Chen 
et al., 2012), PEG-camptothecin (Li et al., 2011), and 
chitosan oligosacharide-doxorubicin (Su et al., 2015). 
However, there are some limitations in using disulphide 
linker such as low drug payload, low physical stability 
and possibility of change in chemical structure of the 
drugs after being released, and therefore requires further 
studies on destabilization and preclinical evaluation 
(Chang et al., 2016).
Required Characteristics of the Polymer
Water Solubility and Reactive Functional Groups
Functional groups of polymer play some important roles. 
They determine polymer properties in solution, including 
solubility, and also provide reactivity for conjugation 
with other molecules. Normally, natural polymers have 
hydroxyl (-OH) and /or carboxylic (-COOH) groups. 
Chitosan is one of natural polymers that has primary 
amine (-NH2) group. Those functional groups provide 
hydrophilicity as well as reactivity for conjugation 
reaction. However, some natural polymers, such as 
starch and original cellulose that mainly consist of –OH 
groups, are not water soluble. Their insolubility in water 
is suspected due to strong intermolecular hydrogen 
bonds or hydrophobic interaction (Medronho, Romano, 
Miguel, Stigsson, & Lindman, 2012). Therefore, the 
choice of natural polymers candidate for a drug conjugate 
should be based on not only their available functional 
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groups but also their solubility in water. Below are some 
water-soluble natural polymers that have been studied 
as carrier in polymer-drug conjugates. The structure of 
each polymer can be seen in Figure 2.
Dextran. Dextran is a polymer of α-ᴅ-glucopyranosyl 
with (1,6)-linked α-ᴅ-glucopyranosyl unit (BeMiller, 
2003). Dextran is synthesized from sucrose by certain 
lactic-acid bacteria, the best known are Leuconostoc 
bacteroides and Streptococcus mutans. Dextran is 
normally used as plasma volume expander (Svens & 
Rodhe, 2013). 
Dextran is probably the most investigated natural 
polymer derivate in polymer-drug conjugates, which 
has been developed for various types of disease. For 
example, daptomycin-dextran conjugates showed higher 
affinity for fibrinogen than free daptomycin, suggesting 
improvement of daptomycin efficacy in endocarditis 
(Muangsiri & Kirsch, 2006). Varshosaz et al. (2011) 
synthesized budenoside-dextran conjugate as colon-
targeted drug delivery system for ulcerative colitis 
medication. Cathecin, a flavonoid, was also conjugated 
to dextran for the treatment of pancreatic ductal 
adenocarcinoma (Vittorio et al., 2012). 
Dextrin. Dextrins are a group of oligosaccharides which 
derived from partial hydrolysis of acid or amylases 
action (BeMiller, 2003). It is a mixture of ᴅ-glucose unit 
polymer linked by (1,4) or (1,6) glycosidic bonds (Y. 
Zhao & Tu, 2013). Corn starch is generally used as the 
most common sources of dextrins due to its availability in 
nature and its low production cost, even though starches 
from potato, tapioca and sago are considered easiest to 
Figure 2. Structure of Some Water-soluble Natural Polymers
be converted to dextrins (Baumann & Conner, 1994).
As carrier in drug delivery system, they are usually 
modified into succinoylated-dextrin which undergo 
slower rate of degradation by pancreatic α-amylase 
(Hreczuk-Hirst, Chicco, German, & Duncan, 2001). 
Hardwicke et al., (2008) used succinoylated-dextrin as 
carrier for recombinant human epidermal growth factor 
(rhEGF) for wound healing. The conjugates showed 
elevated stability against degradation by trypsin and 
neutrophil elastase. Succinoylated-dextrin was also used 
to conjugate an antitumor protein, phospholipase A2 
(PLA2), as synthesized by Ferguson & Duncan (2009). 
The conjugate showed lower PLA2’s hemolytic activity 
with similar, or higher, cytotoxicity against MCF-
7, HT29, and B16F10 cells, compared to free PLA2. 
Ferguson, Azzopardi, Roberts, Walsh, & Thomas (2014) 
successfully synthesized dextrin-colistin conjugates. 
Although the conjugates diminished the antimicrobial 
activity of colistin, they showed prolonged plasma 
retention and reduced toxicity, in comparison to colistin 
sulfate.
Pullulan. Pullulan is a natural-derived  consisted of 
maltotrioses, linked by α-(1,6)glycosidic bond, which 
consists of three molecules of glucose linked to each 
other with α-(1,4) glycosidic bond (Chiellini, Piras, 
Errico, & Chiellini, 2008; dos Santos & Grenha, 2015; 
Mizrahy & Peer, 2012; Namazi, Fathi, & Heydari, 
2012; Singh, Kaur, Rana, & Kennedy, 2017). This 
structure is suggested to give pullulan high flexibility 
and water solubility (Kumar, Saini, Pandit, & Ali, 2012; 
Trinetta & Cutter, 2016). Pullulan is an extracellular 
polysaccharide. It was first reported from the strains of 
fungus Aureobasidium pullulans (Bender, Lehmann, 
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& Wallenfels, 1959; Park & Khan, 2009). The fungus 
cultivation parameters strongly affect the resulting 
pullulan MW, which is usually ranging from 4.5 x 104 
– 6 x 105 Da (Cheng, Demirci, & Catchmark, 2011; dos 
Santos & Grenha, 2015).
In a research by  Zhang et al. (2011), pullulan-
doxorubicin conjugate showed greater toxicity 
(determined by IC50) toward ovarian carcinoma A2780 
cells compared to free drugs after 48 hours incubation. 
Scomparin, Salmaso, Bersani, Satchi-Fainaro, & 
Caliceti (2011) demonstrated opposite result, where 
the polymer conjugation showed lower toxicity than 
free doxorubicin. However, the conjugates showed 
significant improvement in pharmacokinetics, with half-
life (T
1/2β
) ~4 times longer than the parent drug. Beside 
drug, pullulan was also used to synthesized conjugates 
that bring gadolinium diethylene triamine pentaacetate 
(Gd-DTPA) for contrast agent in MRI (Yim et al., 2011). 
The conjugates showed high accumulation in the liver, 
which suggests hepatocyte-specific MRI contrast agent.
Chitosan. Chitosan is a polymer obtained from 
partial N-deacetylation of chitin, found in crustacean 
shells (Emeje & Anwunobi, 2011; Hamed, Özogul, 
& Regenstein, 2016). Chitosan and chitin structure is 
similar to cellulose. In chitin and chitosan, the hydroxyl 
at C-2 position replaced by acetamide groups (Islam, 
Bhuiyan, & Islam, 2017). Chitosan is composed of 
N-acetyl glucosamine and glucosamine residues which 
covalently linked by linear β-(1,4) glycosidic bonds 
and obtained by transforming its acetamide groups into 
primary amino groups (Hamed et al., 2016; Islam et al., 
2017).
Chitosan has been widely explored in gene delivery. 
The positively charged amino group of chitosan can 
create electrostatic attraction with the negatively 
charged nucleic acid to make a complex and therefore 
can protect the gene from plasma nucleases (Saranya, 
Moorthi, Saravanan, Pandima Devi, & Selvamurugan, 
2010). However, chitosan now is also used for wider 
application. For example, conjugates of N-succinyl-
chitosan and carboxymethyl-chitin with chemotherapy 
drug mitomycin C (MMC) for slow release MMC (Song, 
Onishi, & Naai, 1992). Other example is conjugation 
of paclitaxel to low molecular weight chitosan, as 
synthesized by Lee et al. (2008), that showed ~42% 
per oral bioavailability and increased solubility, 
suggesting the possibility to deliver paclitaxel via oral 
route. Chitosan was also used to carry near infra red 
(NIR) dye IR820 for cancer theranostic application 
(Srinivasan, Manchanda, Fernandez-Fernandez, Lei, & 
Mcgoron, 2013).  Conjugation of exendin-4, a GLP-1 
mimetic peptide for treatment of type 2 diabetes, to low 
molecular weight chitosan showed improved stability 
against trypsin and better oral pharmacokinetics profile 
(Ahn et al., 2013). These findings indicate the prospect 
to create an orally bioavailable peptide drugs.
Hyaluronic Acid. Hyaluronan is an international 
nomenclature of heteropolysaccharides attributed to 
Endre Balazs. It encompasses the term of two different 
forms of the molecule e.g. the acid form, hyaluronic acid; 
and its salt, hyaluronate, such as sodium hyaluronate 
(Balazs, Laurent, & Jeanloz, 1985). At physiological 
pH, its carboxyl groups form anionic charge and 
balanced with cation such as sodium, potassium, 
calcium or magnesium (Fallacara, Baldini, Manfredini, 
& Vertuani, 2018). Hyaluronan is an extracellular 
matrix compound. It is a highly molecular weight 
glycosaminoglycans, composed of disaccharide repeats 
of N-acetylglucosamine and glucoronic acid linked 
together by alternating β-(1,4) and β-(1,3) glycosidic 
bonds (Necas, Bartosikova, Brauner, & Kolar, 2008). 
The number of repeating disaccharides in a hyaluronan 
can achieve 10,000 or more with molecular mass about 
4 million Dalton (Cowman & Matsuoka, 2005; Necas et 
al., 2008).
Homma et al. (2010) optimized hyaluronic acid-
methotrexate conjugates formulation to obtain best 
characteristic for ostheoarthritis treatment. Conjugation 
with hyaluronic acid can also enhance solubility of 
curcumin as shown by Manju & Sreenivasan (2011). Like 
other natural polymers mentioned before, hyaluronic 
acid has also been employed as carrier for paclitaxel 
(H. Lee, Lee, & Park, 2008; Yin et al., 2015; D. Zhao, 
Zhang, Yang, He, & Luan, 2016).
Pectin. Pectins are a member of polysaccharides 
which commonly present in primary cell walls and 
middle lamella of dicotyledonous and non-grass 
monocotyledonous plants (Gawkowska, Cybulska, 
& Zdunek, 2018). Pectins are mainly consisted of 
covalently linked galacturonic acid  by linear chain 
α-(1,4) glycosidic bonds that forms the backbone 
of pectin, homogalacturonan (Human Metabolomic 
Database, 2018; Mohnen, 2008; Wishart et al., 2018).
The fine structures of its polysaccharides are never 
fully known or defined, and at first were thought to be 
triad homopolymers i.e. homogalacturonan, arabinan 
and galactan. Afterward, the reports from various plant 
materials showed that pectic subtances is a group of 
complex and diversified polysaccharides, with molecular 
weight more than 200.000 Dalton, which correspond to 
polymerization degree (Flutto, 2003; Yapo, 2011).
Pectin, depending on the degree of esterification, 
has carboxylic groups. In this case, the degree of 
esterification (DE) of pectin affects many properties 
of pectin polymer, i.e. gelling properties, and therefore 
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affects its functionality (Lutz, Aserin, Wicker, & Garti, 
2009; Morris, Kok, Harding, & Adams, 2010).
Tang et al. (2010) synthesized pectin-adriamycin 
conjugate which exhibited remarkable therapeutic 
effect on melanoma pulmonary metastasis a (B16 
cell line) in C57BL/6 mice (shown by lung histology 
and percent of survival after 60 days tumor implant). 
Cheewatanakornkool, Niratisai, Manchun, Dass, 
& Sriamornsak (2017) also used the same drug to 
conjugate with thiolated pectin. The conjugates were 
then crosslinked by ionotropic gelation technique to 
produce microbeads with particle size ~1000 μm.
Arabinogalactan. Arabinogalactan is a water-soluble 
polysaccharide that is found in various plants such as 
Cuscuta chinensis, Larix occidentalis, Larix sibirica 
and many more (Paulsen & Barsett, 2005). It has some 
bioactive properties such as effects on macrophages, 
T-lymphocytes and NK-cells (Paulsen & Barsett, 2005). 
The (1,3)-linked β-ᴅ-galactopyranose units [→3)-β-ᴅ-
Galp-(1→] build the main chain, with branching points 
at the C6 atom (Mikhailenko et al., 2016). The branching 
consists of 3,6-di-O-substituted and 6-O-substituted 
galactopyranosyl, 3-O-substituted arabinofuranosyl 
residues, as well as arabinofuranosyl, arabinopyranosyl 
and galactopyranosyl non-reducing terminal units.
In a study conducted by Pinhassi et al. (2010), 
arabinogalactan was used to create targeted delivery and 
target-activated release of methotrexate, with folic acid 
as targeting moiety. The conjugate exhibited elevated 
cytotoxicity against folate receptor (FR)-overexpressing 
cells compared to FR-lacking cells. Elgart, Farber, 
Domb, Polacheck, & Hoffman (2010) compared low 
molecular weight (L-Mw) and high molecular weight 
(H-Mw) arabinogalactan as carrier for amphotericin B. 
The result showed altered pharmacokinetics parameters 
of conjugates compared to free amphotericin B, 
where conjugation of amphotericin B with H-Mw 
arabinogalactan showed significant decreased in volume 
of distribution and clearance. Arabinogalactan was also 
used to carry gadolinium-diethylenetriaminepentaacetic 
acid for liver-specific MRI contrast agent (Li et al., 
2008).
Molecular Weight and Dispersity
Molecular weight plays an important role in 
nanoparticle’s behavior in the body. As mentioned 
before, in order to exhibit prolonged plasma circulation, 
a polymeric carrier should be larger than 40 kDa, which 
is the threshold of renal clearance (Fang et al., 2011). In 
case of hydrodynamic size, the size should be maintained 
5.5 – 150 nm to avoid renal clearance (Choi et al., 2007) 
as well as to escape phagocytic uptake (He, Hu, Yin, 
Tang, & Yin, 2010).
Dispersity (Ð, pronounced “D-stroke”), which replaces 
the misleading but widely used term “polydispersity 
index”, is “dispersions of distributions of molar masses 
(or relative molecular masses, or molecular weights) and 
degrees of polymerization” (Stepto, 2010). In a simple 
way, dispersity is the ratio between weight average 
molecular weight and number average molecular weight 
(Mw/Mn). Dispersity index of a highly uniform polymer 
is 1, and this can only be obtained by protein. Other type 
of polymers have dispersity more than 1. For polymer-
drug conjugates, the dispersity of the polymeric carrier 
should be as close as 1.
When using polymer as excipient in drug dosage form, 
dispersity index is not essential. On the other hand, for 
polymers that are “therapeutically active” like polymer-
drug conjugates, the dispersity, which correlates with 
molecular weight distribution, becomes important. First, 
from the conjugation reaction point of view, dispersity 
is important to determine the stoichiometry. Broad 
dispersity means broad molecular weight distribution, 
which also means vary individual chain length. If this 
exists, it will be difficult to determine the molar ratio 
between polymer and drugs in the conjugation reaction. 
Second, from the therapeutic dose point of view, 
dispersity is essential to determine the dose. The number 
of drug molecules per polymer chain should be well 
defined to ensure the proper therapeutic dose.
The challenge of using natural polymer as carrier in 
polymer-drug conjugates is the wide range of molecular 
weight, depending on the sources. For example, 
arabinogalactan from gum Arabic, mango fruit exudate, 
and larch have Mn 71.6 kDa, 19.8 kDa, and 8.85 kDa, 
respectively (Nagel, Conrad, Leitenberger, Carle, & 
Neidhart, 2016). Chitosan sold by Sigma-Aldrich is 
available in wide variety of molecular weight, ranging 
from 5 to 375 kDa. Therefore, researcher need to pre-
define the molecular weight and origin of the natural 
polymers prior to use it.
Technical Aspect on Synthesis and Analysis
Conjugation of Drugs and Targeting Moieties to 
Polymeric Carrier
Many conjugation techniques can be an option. The 
choice of conjugation technique depends on the 
functional groups present on both polymer and the small 
molecule (Hermanson, 2013). Moreover, the functional 
groups should be available and chemically compatible 
to make the reaction possible (Hermanson, 2013). 
Meanwhile, polymer chain in solution tend to form 
random, three-dimensional coil (Edvinsson, 2002). This 
conformation becomes a great challenge in conjugation 
reaction between polymer and small molecule because 
some of the reactive groups in polymer are hindered 
inside the conformation and inaccessible.
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Different technique of conjugation are available for each 
kind of linkage. Generally, amide and ester are the most 
used for small molecule drugs, while thiol conjugation is 
more common for protein and peptide drugs. Therefore, 
in this review we will focus on the amide or ester 
conjugation reaction.
Amide bonds are basically created from condensation of 
carboxylic acids and amines. However, the reaction does 
not occur spontaneously at room temperature. It needs 
activation of carboxylic acid by converting the –OH of 
the acid into a good leaving group (Valeur & Bradley, 
2009). Once it is activated, the amines will be easier to 
replace the –OH of the acid to form amide bond.
Activation of carboxylic acids needs coupling reagents 
and the choice of coupling reagent is essential for 
the success of reaction. Carbodiimides were the first 
coupling agents to be synthesized and are still widely 
used. They are called as zero-length crosslinking 
agent because no additional chemical is incorporated 
between the conjugated molecules (Hermanson, 2013). 
N-substituted carbodiimides can react with carboxylic 
acids to form o-acylisourea derivatives (Figure 3). This 
o-acylisourea intermediate is a highly reactive species 
and can be replaced by a nucleophile such as a primary 
amine to form an amide bond. There are three well-known 
carbodiimide derivates: dicyclohexylcarbodiimide 
(DCC), diisopropylcarbodiimide (DIC), and 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide hydrochloride) 
(EDC). DCC and DIC are water-insoluble reagents and 
thus can only be used for reaction in organic solvent. 
EDC is water soluble and therefore suitable for aqueous-
based reaction. Addition of sulfo-NHS ester is sometimes 
required to reduce early hydrolysis of active carboxylates 
and thus increase the conjugation efficiency.
Ester bond formation uses the same principle as 
amide. However, it requires catalytic agent such as 
dimethylaminopyridine (DMAP). Addition of DMAP 
brings formation of acyl pyridinium intermediate which 
then reacts with alcohol to form ester product as shown 
in Figure 3 (Lutjen, Quirk, Barbera, & Kolonko, 2018). 
Figure 3. General Mechanism of Amide and Ester Formation Using Carbodiimide as 
Coupling Agent (adapted from Hermanson, (1996) & Lutjen, Quirk, 
Barbera, & Kolonko (2018))
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Analytical Technique
Size Exclusion Chromatography. Size exclusion 
chromatography (SEC) or gel permeation 
chromatography (GPC) is basically one type of 
high performance liquid chromatography (LC). The 
fundamental difference between SEC and HPLC is in the 
principle of molecule separation. While HPLC separates 
molecules based on their hydrophilicity-hydrophobicity 
nature, SEC dissociates molecules solely based on their 
size. SEC uses columns packed with very small, round, 
porous particles which are made from insoluble cross-
linked polymers or inorganic materials, such as spherical 
silicas (Agilent, 2015).
As mentioned before, when dissolved in a solvent, 
polymer chain will coil up to form a ball of string. Inside 
the SEC column, the polymer conformation will behave 
like spheres. The size of the sphere is molecular weight 
dependent, where higher molecular weight polymer 
will form larger spheres. When the polymer coils pass 
through the porous beads in SEC column, those that are 
bigger than the largest pores in the beads are not able 
to enter the pores and therefore exit the column first. 
The medium size polymer coils can probably enter the 
biggest pores, but not the small ones. As a result, these 
coils will exit later than the larger ones. The smallest 
polymer coils can occupy any pores in the beads and 
therefore will be retained much longer. As the fractions 
exit the column, they are measured by certain detector 
(mostly refractive index detector) and then compared 
with calibration standard (e.g. polystyrene). The elution 
profile of the sample will be displayed in chromatogram. 
Illustration of SEC mechanism is shown in Figure 4. 
With SEC, the value of Mn, Mw and dispersity can be 
obtained and thus, SEC becomes the most regularly used 
method for molecular weight determination of polymers.
Nuclear Magnetic Resonance. Nuclear magnetic 
resonance (NMR) spectroscopy is a well-established 
method for the characterization of molecules, including 
polymers. It has been applied for the determination 
of polymerization conversion and kinetics (Favier, 
Charreyre, & Pichot, 2004; Martin, Gody, & Perrier, 
2015), monomer sequence in copolymer (Hatada & 
Kitayama, 2004), molecular weight of polymer (Izunobi 
& Higginbotham, 2011) and successful conjugation of 
drug to polymer (Hu et al., 2014; Lv et al., 2014). 1HNMR 
spectroscopy is considered as a fast, reproducible, and 
relatively simple technique for polymer-drug conjugates 
structure elucidation.
Mass Spectrometry. Large molecules have triggered 
progress development of efficient ionization methods for 
mass spectrometric analysis especially in the structural 
analysis of biomacromolecules. These were overcome 
first by fast atom bombardment (FAB), and since the 
late 1980s more efficiently by electrospray ionization 
(ESI) and matrix-assisted laser desorption/ionization 
(MALDI) (Aminlashgari & Hakkarainen, 2011). The 
application of ESI and MALDI have been widely 
applied for biomolecules of oligo- and polymeric size, 
in combination with appropriate mass analyzers such as 
instruments, quadrupoles, ion traps, and time-of-flight 
tubes (Aminlashgari & Hakkarainen, 2011). To be more 
attractive, the techniques are also combined with tandem 
mass spectrometry. 
Figure 4. Illustration of Polymer Separation by GPC 
(adapted from Agilent Technologies Inc., (2015))
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Analysis of polymer and biomacromolecule are suitable 
with soft ionization mass spectrometric techniques. 
There are two approaches for analyzing polymer (1) 
Top-down approach; polymer was analyzed for its 
higher-order structure. For top-down approach matrix-
assisted laser desorption/ionization-mass spectrometry 
(MALDI-MS) was widely used; (2) Bottom-up 
approach; polymer was cut into smaller fragments 
of oligomer and reconstructed back into its original 
form. For bottom-up electrospray ionization-mass 
spectrometry (ESI-MS) has been excellent techniques 
for the analysis of the synthetic polymer. For high 
molecular mass polymer analysis, MALDI-MS is the 
best choice because of its soft ionization. Soft ionization 
was achieved by the interaction between the matrix 
and the polymer. MALDI-MS makes polymers can be 
analyzed in their original structure. Thus, it is possible 
to acquire more information about structural differences 
among polymers. Liquid chromatography equipped with 
ESI-MS is the best choice for monomer analysis of the 
polymer.
When dealing with polymers with high molecular 
mass distribution, ESI-MS can create multiple charged 
ion adducts that can be a problem. Carbohydrates 
commonly form alkali adducts. Also, compared to 
proteins and peptides, poly- or oligosaccharides show 
lower surface activity, higher polarity, and are less stable. 
Table 1. Common Amines for labeling by Iminium Ion Formation (Harvey, 2000)
No Amine Abbreviation Mass Increment Structure
1 2-aminobenzamide 2-AB 120 O
NH2
NH2
2 2-aminopyridine 2-AP 78 N NH2
3 2-aminoacridone 2-AMAC 194
N
H
NH2
O
4 3-aminoquinoline 3-AQ 128 N
NH2
5 4-aminobenzoic 
acid methyl ether
ABME 135 O
O
H2N
6 4-aminobenzoic 
acid ethyl ether
ABEE 149 O
O
H2N
7 4-aminobenzoic 
acid n-butyl ester
ABBE 176 O
O
H2N
8 4-amino-N-(2-di-
e t h y l a m i n o e t h -
yl)-benzamide
DEAEAB 219
O
N
H
N
H2N
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Carbohydrates alkali adducts often show dispersity 
of molecular mass and chemical structure, and due to 
many stereochemical centers have isobaric ions, which 
cannot easily be differentiated by MS. The drawback 
with MALDI is the difficulty in studying these low 
mass range and often makes it impossible to detect low 
molecular weight compounds.  
The presence of charged species determined MS 
analysis. Although both positive and negative ion can 
run simultaneously, positive mode is more common and 
therefore preferentially chosen. Carbohydrate is generally 
neutral and, apart from amino sugars, possess no basic 
groups that are able to be protonated. More common 
is, thus, the information of adducts with metal cations, 
mainly alkali ions, and preferentially the presence of 
sodium ion. Ion yield and the sensitivity of MS depend 
on appropriate coordination sites. The oxygen atoms 
achieve coordination with their nonbonding electron 
pairs (Crecelius, Vitz, & Schubert, 2014). 
Chemical modification is the selective incorporation of 
a tag which has a readily ionizable functional group, 
often a quaternary ammonium group. Also, most of 
the tags are chromophores, and some of them are also 
fluorescent, which is useful for parallel detection in 
liquid chromatography. The most popular reactions are 
imines, and usually followed by a reduction to transfer 
the reversibly formed intermediate imines to the stable 
amines (Crotty, Gerişlioğlu, Endres, Wesdemiotis, & 
Schubert, 2016). Figure 5 shows the reaction between 
β-glucose with 2-aminobenzamide forming the iminium 
ion which can be detected by MS using positive ion 
Figure 5. Iminium Ion Formation of β-glucose and 2-aminobenzamide 
(Unterieser, 2011)
mode. Several reagents were used to produce iminium 
ion as described in Table 1.
a. Linear homopolymer analysis using thermal-MS 
      techniques
Thermal-MS techniques can decompose polymer by 
heat. Afterward, polymers are then analyzed by mass 
spectrometer to observe the degradation product of the 
polymer. Characterization of the temperature-dependent 
degradation product is useful to obtain information 
regarding both physical and structural properties. It is 
reported that simultaneous thermogravity-differential 
thermal analysis coupled with miniaturized ion trap 
MS allowed precise real-time monitoring analysis of 
activated organic compounds such pas pyrolysates. 
These features allow a better understanding of the 
complex thermal behavior and the precise pyrolysates 
material (Paine, Barker, & Blanksby, 2014; Wang, 1999).
b. Linear copolymer analysis using direct MS/MS 
      techniques
Polymer sample can be directly injected to the mass 
spectrometer without preparation. The analyte ions are 
then fragmented to give more detailed structural and/
or architectural information. The tandem MS analysis 
can be executed using various scanning modes such 
as selective ion monitoring (SIM), precursor ion scan, 
selected reaction monitoring, and multiple reaction 
monitoring (MRM). Out of all these modes, selective ion 
monitoring is one of the most common MS/MS modes to 
characterize the structure of various synthetic polymers. 
During this mode, a precursor analyte ion is isolated, 
followed by activation and fragmentation inside the 
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mass spectrometer. Finally, all fragmentation products 
are scanned and analyzed for more detailed investigation 
of the precursor ion structure (Crotty et al., 2016; Paine 
et al., 2014).
c. Complex polymer analysis using LC-MS based 
      techniques
It has been proven that there are some cases where MS 
alone is insufficient for a comprehensive characterization 
of end groups, copolymer composition sequences, etc. 
Therefore, some techniques have been developed to 
obtain a more detailed polymer characterization, which 
involve hyphenation with HPLC either separating 
by polarity or size or 2D-LC. Many different 1D-LC 
systems hyphenated with MS are reported, particularly, 
for optimizing the transfer of the sample from a 
chromatographic system to the mass spectrometer. 
The main advantage of ESI is its compatibility with 
continuous hyphenation to diverse HPLC modes in 
comparison to MALDI, where most of the hyphenation 
techniques are carried out offline. Different hyphenations 
and different detectors are used to obtain extra knowledge 
about polymers, such as chemical heterogeneity and 
isomeric architecture (Sarrut, Crétier, & Heinisch, 2014). 
Therefore, enabling the chemist to improve synthetic 
routes.
A 2D (RP-LC X SEC) chromatography system can also 
be tandemed with MALDI and ESI. The procedure is 
fully automated and very versatile. The RP-LC X SEC 
combination appears to be one of the most important 
analytical methods when specific conditions are applied 
in the first dimension (Trathnigg, 1995). Figure 6 shows 
analytical workflow of oligosaccharide conjugated with 
amine to form imine.
d. Complex polymer analysis using ion mobility-MS 
     (IM-MS) techniques
IM spectrometry provides an additional dimension for 
elucidating different conformations or architectures 
present in an analyte. With IM-MS, gas phase ions are 
separated based on their mobility and composition. 
Information obtained by IM separation can be used 
to create collision cross-sections, which are directly 
related to the macromolecular shape. Isobaric ions are 
two different chemical species with different elemental 
composition, having the same nominal mass (mass 
difference at ppm level). They often appear in polymer 
analysis and can only be resolved by high-resolution 
spectra. If isobaric species are not solved, obtaining 
a detailed structural characterization with MS/MS 
experiments can be very challenging. This can result in 
very complicated MS/MS data, having fragment ions from 
both species in the same spectrum (Crotty et al., 2016). 
Figure 6. Analytical Workflow of Oligosaccharide-imine Conjugate
Figure 7. Some Techniques to Purify Polymer-Drug 
Conjugates: (a) Precipitation, (b) Dialysis, (c) Ultrafiltration by 
Centrifugation, and (d) Desalting Column
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Purification of Conjugates
Pure conjugates are required for in vitro and in vivo 
studies in order to avoid false positive or negative. The 
conjugates must not contain free unreacted drugs that 
can bias the in vitro and in vivo study results. There are 
some purification technique that can be used to separate 
conjugates and the unreacted drugs, which include 
precipitation, dialysis and desalting column.
Precipitation is one simple way to isolate and purify 
polymers from small molecules. The technique needs a 
solvent that is “poor” for the polymer and “good” for 
the drug. A solution that contains a mixture of polymer 
and free drugs is then poured into the “poor” solvent, 
leading to precipitation of the polymer while leaving the 
free drugs in supernatant (see Figure 7a).
Dialysis involves a semi-permeable membrane with 
certain molecular weight cut off (MWCO). The principle 
is basically retention of molecules larger than MWCO 
in the donor compartment, while all molecules smaller 
than MWCO pass through the membrane into the 
acceptor compartment (Figure 7b). The migration of 
the molecules from donor to acceptor compartment will 
reach equilibrium, a condition where the concentration 
of the molecules in donor compartment is equal to that 
in acceptor compartment. In equilibrium state, there 
will be no more diffusion of the molecules through 
the membrane because of concentration gradient. The 
solvent in acceptor compartment must be regularly 
replaced with the new one in order to maintain the 
concentration gradient, and therefore allow the diffusion 
of the small molecules.
Other technique that adopts the principle of dialysis 
is ultrafiltration by centrifugation (Figure 7c). This 
technique requires centrifugation tube, which consists of 
two membrane-separated compartments. The membrane 
is also semipermeable and has MWCO. The solution of 
conjugates and drugs mixture is placed in the upper part of 
the tube (donor compartment), and then centrifuged. The 
centrifugation force will pull down the solvent through 
the membrane, together with the molecules smaller than 
MWCO and the solution residue that contains conjugates 
will stay in the upper part. By adding a new solvent to 
the donor compartment, and repeat the centrifugation for 
several times, pure conjugates can be obtained.
Desalting column is also a versatile tool to purify 
macromolecules. The principle of desalting column 
is basically similar to size exclusion chromatography, 
which is separation based on the molecular size. The 
solution of conjugates and drugs mixture is passed 
through the column and then the eluted fractions are 
collected (Figure 7d). All fractions are then analyzed, 
e.g. by HPLC, to confirm which fractions contain 
conjugates.
CONCLUSION AND FUTURE PERSPECTIVE
Natural polymers are potential candidate for carrier in 
drug delivery system. There are numerous studies in 
polymer therapeutic using natural polymer. However, 
we have not found any international publication in this 
field from Indonesian researcher. Therefore, we would 
like to encourage Indonesian researcher to explore this 
area, which includes production of pure natural polymer 
with well-defined characteristic, synthesis of polymer-
drug conjugate to improve the efficacy of commercially 
available drugs, in vitro and in vivo study of the 
conjugates, as well as clinical study. Technical aspects 
in synthesis and analysis might become challenges 
due to limited facilities and analytical instruments. For 
example, Nuclear Magnetic Resonance (NMR) is not 
commonly available in every research institution. There 
are only few institutions in Indonesia that have NMR 
facility, including Research Center for Chemistry LIPI 
(Serpong), Universitas Gadjah Mada (Yogyakarta), 
Airlangga University (Surabaya), and Bandung Institute 
of Technology (Bandung). Therefore, collaboration 
between institutions, as well as government role 
in mapping and providing the required analytical 
instruments and facilities, are essential. Furthermore, 
collaboration between different experts, including 
medicinal chemists, organic chemists, pharmacists and 
clinicians, is also utmost important. 
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